### MDMA + Ketamine Therapeutic Blend

This specialized research blend combines the empathogenic properties of MDMA with the dissociative and neuroplastic effects of Ketamine. It is designed for researchers investigating novel therapeutic protocols for treatment-resistant conditions.

**Formulation:**
- **Ratio:** 2:1 (MDMA HCl to Ketamine HCl)
- **Form:** Homogeneous crystalline powder blend
- **Purity:** Both components >99.5% pure

**Research Applications:**
- Treatment-resistant depression models
- PTSD and trauma processing studies
- NMDA and SERT receptor interaction research
- Synergistic neuroplasticity investigations

**Quality Assurance:**
- HPLC verification of blend ratio
- Individual CoAs for MDMA and Ketamine
- Heavy metals and residual solvent screening

**Storage:**
- Store at room temperature (15-25°C)
- Protect from light and moisture
- Keep container tightly sealed

Provided exclusively to qualified research institutions with appropriate ethical and regulatory approvals.